• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Investing

Is it safe to buy Kimberly-Clark stock after disappointing Q3 results?

by October 25, 2021
by October 25, 2021

On Monday, Kimberly-Clark Corporation (NYSE:KMB) shares fell by more than 5% after announcing its fiscal third-quarter results. The company reported its most recent quarterly results before the market opened, missing analyst expectations on earnings. However, KMB’s revenue for the quarter edged higher, outperforming the average for analyst estimates.

The company posted FQ3 non-GAAP earnings per share of $1.62, missing the consensus Street estimate of $1.65. In addition, its GAAP EPS of $1.39, was $0.19 below estimates, while the quarterly revenue increased by 7.1% from the same period a year ago, $50 million ahead of the average for analyst forecasts.

Moreover, Kimberly-Clark lowered its fiscal FY2021 earnings guidance to $6.05-$6.25 from $6.65-$6.90, well below the average Street forecast of $6.70.

Is KMB stock overvalued?

From an investment perspective, Kimberly-Clark shares trade at reasonable trailing 12-month and forward P/E ratios of 21.40 and 16.73, respectively. Therefore, some value investors could find it as an exciting option for their portfolios.

However, given the company’s recent quarterly earnings miss, the current analyst earnings forecasts of 10% this year and 11.44% next year may be overstated.

Therefore, although the stock is down nearly 6% this year, it may not be time to buy KMB shares.

Source – TradingView

Technically, Kimberly-Clark shares seem to be trading within a descending channel formation following Monday’s post-earnings plunge. As a result, the stock has moved closer to the oversold conditions of the 14-day RSI.

In addition, the KMB stock price has fallen to retest the trendline support, creating an opportunity for a rebound. Therefore, investors could target short-term rebounds at about $131.43, or higher at $136.34, while $122.30 and $116.48 are support levels.

It may not be time to buy KMB shares

In summary, although Kimberly-Clark shares have plummeted to trade at a new 52 week low of about $125.32, the stock still seems to be trading under immense bearish pressure whilst lacking catalysts for a potential rebound.

The post Is it safe to buy Kimberly-Clark stock after disappointing Q3 results? appeared first on Invezz.

0 comment
0
FacebookTwitterPinterestEmail

previous post
BMO Capital’s Siegel: the future of retail is brick and mortar
next post
Facebook blames Apple as sales fall shy of estimates in Q3

Related Posts

Deere down 15% despite strong results: ‘I like...

May 20, 2022

Twitter stock won’t ‘fall a whole lot’ if...

May 20, 2022

Jablonski is bullish on Amazon: ‘a lot of...

May 20, 2022

Alibaba stock price outlook: Why BABA is a...

May 20, 2022

Deckers Outdoor opened 20% up on Friday: what...

May 20, 2022

Palo Alto Q3 results: ‘getting more interest from...

May 20, 2022

Expert opinion: JPMorgan stock down 30% isn’t ‘that...

May 19, 2022

S&P 500 falls again as bears push stocks...

May 19, 2022

Ross Stores shares tank 25% on Q1 results

May 19, 2022

Bill Nygren gives away his favourite financial stock

May 19, 2022

Recent Posts

  • Deere down 15% despite strong results: ‘I like it for long-term’

    May 20, 2022
  • Twitter stock won’t ‘fall a whole lot’ if Musk walks away

    May 20, 2022
  • Jablonski is bullish on Amazon: ‘a lot of the issues are resolvable’

    May 20, 2022
  • Alibaba stock price outlook: Why BABA is a bargain

    May 20, 2022
  • Superstitious Storytellers

    May 20, 2022
  • Deckers Outdoor opened 20% up on Friday: what happened?

    May 20, 2022

Editors’ Picks

  • 1

    2 Canadian marijuana stocks to keep a close eye on

    February 5, 2022
  • 2

    Nvidia Corporation earnings beat not sufficient to boost stock – Is it a good buy?

    February 18, 2022
  • 3

    The IMF Should Be Eliminated, Not Expanded

    October 12, 2021
  • 4

    Micron Technology shares are trading lower after-hours: here’s why

    September 29, 2021
  • 5

    Here’s what inflation might look like in 2022

    November 23, 2021
  • 6

    Is Clorox stock a good buy ahead of its fiscal Q1 2022 results?

    October 30, 2021
  • 7

    Vaccine Authoritarianism Explained

    November 6, 2021
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Categories

  • Economy (812)
  • Editor's Pick (310)
  • Investing (2,500)
  • Stock (10)
About Us Terms & Conditions Privacy Policy Email WhiteListing Contact Us

Disclaimer: Portfolioperformancetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick

Read alsox

Pro: it’s time to switch to the...

December 20, 2021

Where to buy the First Horizon stock:...

February 28, 2022

Gina Sanchez: ‘Amazon’s going to have the...

May 2, 2022